Difference between revisions of "Heart transplant pathology"
Jump to navigation
Jump to search
m (→IHC: w) |
|||
(30 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
'''[[Heart]] transplant pathology''' is a niche in [[cardiac pathology]]. | '''[[Heart]] transplant pathology''' is a niche in [[cardiac pathology]]. | ||
==Overview - table== | |||
===Types of rejection<ref name=Ref_WMSP136-7>{{Ref WMSP|136-7}}</ref>=== | |||
{| class="wikitable" | |||
| Type (grade) | |||
| Description | |||
| Details | |||
| Image | |||
|- | |||
| antibody-mediated rejection (acute vascular) | |||
| edema, dilated small vessels | |||
| scant inflammation | |||
| [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4 acute] | |||
|- | |||
| normal (0R) | |||
| normal | |||
| no extravascular monocytes | |||
| | |||
|- | |||
| acute cellular (1R) | |||
| (perivascular) inflammatory infiltrate, myocyte damage | |||
| scant interstitial infiltrate (lymphoplasmacytic), scant damage | |||
| [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig1 mild cellular] | |||
|- | |||
| acute cellular (2R) | |||
| (perivascular) inflammatory space-occupying lesion | |||
| diffuse interstitial infiltrate displaces parenchyma (lymphoplasmacytic), obvious damage (myocyte eosinophilia or drop-out) | |||
| [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig2 mod. cellular], [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig3 mod. cellular resolving] | |||
|- | |||
| acute cellular (3R) | |||
| disruption of normal arch. | |||
| diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & [[PMN]]s), fibre loss/damage | |||
| | |||
|- | |||
| chronic | |||
| concentric intimal thicking | |||
| internal elastic lamina preserved (unlike [[atherosclerosis]]) | |||
| [http://newsroom.ucla.edu/portal/ucla/srp-view.aspx?id=118724 chronic], [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5 chronic] | |||
|} | |||
===Pitfalls<ref name=Ref_WMSP136-7>{{Ref WMSP|136-7}}</ref>=== | |||
{| class="wikitable" | |||
| Name | |||
| Description | |||
| Details | |||
| Image | |||
|- | |||
| Quilty effect | |||
| endocardial/subendocardial B-lymphocytes (in clusters) | |||
| may extend into myocardium, not assoc. with blood vessels +/-myocyte damage; benign behaviour clinically | |||
| [http://medeponyms.com/entry/7/ Quilty effect], [http://www.e-heart.org/Pages/08_Heart_Transplant/08_Heart_Transplant_ELI%20_001.htm Quilty effect] | |||
|- | |||
| Old biopsy site | |||
| hemosiderin-laden macrophages | |||
| fibrosis/myocyte replacement | |||
| [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig6 old Bx site] | |||
|} | |||
=Mimics= | |||
==Biopsy site reaction== | ==Biopsy site reaction== | ||
===General=== | ===General=== | ||
Line 18: | Line 71: | ||
Image: [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig6 Biopsy site (pathconsultddx.com)]. | Image: [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig6 Biopsy site (pathconsultddx.com)]. | ||
==Acute rejection== | ==Quilty effect== | ||
*[[AKA]] ''endocardial lymphocytic infiltrate''.<ref name=pmid17683180>{{cite journal |author=Tan CD, Baldwin WM, Rodriguez ER |title=Update on cardiac transplantation pathology |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1169–91 |year=2007 |month=August |pmid=17683180 |doi= |url=}}</ref> | |||
===General=== | |||
*Can be confused for rejection. | |||
*Benign behaviour. | |||
Trivia: | |||
*The name ''Quilty'' comes from the patient in which this was first recognized. | |||
===Microscopic=== | |||
Features:<ref name=emed_htp>URL: [http://emedicine.medscape.com/article/1612493-overview http://emedicine.medscape.com/article/1612493-overview]. Accessed on: 8 March 2011.</ref> | |||
*Lymphocytes in clusters (B cells and T cells). | |||
**Associated with the endocardium ("endothelium of the heart"), i.e. on the surface - '''key feature'''. | |||
**Often have capillaries in centre; usu. not associated with large blood vessels. | |||
**Lymphocytes separated by collagen. | |||
Notes: | |||
*No longer subclassified.<ref name=pmid17683180/> | |||
**Traditional classification (by location): | |||
***Quilty A: Endocardial/subendocardial. | |||
***Quilty B: Endocardial/subendocardial + myocardium. | |||
****+/-Myocyte damage.<ref name=pmid9192483>{{cite journal |author=Winters GL |title=The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection |journal=Curr. Opin. Cardiol. |volume=12 |issue=2 |pages=146–52 |year=1997 |month=March |pmid=9192483 |doi= |url=}}</ref> | |||
Images: | |||
*[http://medeponyms.com/entry/7/ Quilty effect (medeponyms.com)]. | |||
*[http://www.e-heart.org/Pages/08_Heart_Transplant/08_Heart_Transplant_ELI%20_001.htm Quilty effect (e-heart.org)]. | |||
===IHC=== | |||
Mix of T cell and B cells:<ref name=emed_htp>URL: [http://emedicine.medscape.com/article/1612493-overview http://emedicine.medscape.com/article/1612493-overview]. Accessed on: 8 March 2011.</ref> | |||
*CD3 +ve. | |||
*CD20 +ve. | |||
Notes: | |||
*ACR is T cells.<ref name=emed_htp>URL: [http://emedicine.medscape.com/article/1612493-overview http://emedicine.medscape.com/article/1612493-overview]. Accessed on: 8 March 2011.</ref> | |||
==Coronary atherosclerosis (ischemic injury)== | |||
===General=== | |||
*Usu. early - related to atherosclerosis in the donor heart. | |||
*Not typically biopsied. (???) | |||
===Microscopic=== | |||
Features: | |||
*Findings seen in [[atherosclerosis]]. | |||
=Rejection= | |||
It comes in different flavours:<ref>URL: [http://emedicine.medscape.com/article/1612493-overview http://emedicine.medscape.com/article/1612493-overview]. Accessed on: 9 Febraury 2011.</ref> | |||
*Antibody-mediated rejection (acute vascular rejection). | |||
*Acute cellular rejection. | |||
*Chronic rejection. | |||
==Antibody-mediated rejection== | |||
*Abbreviated as ''AMR''. | |||
===General=== | |||
*[[AKA]] ''acute vascular rejection'', ''hyperacute rejection'', ''humoral rejection''.<ref name=pmid17683180>{{cite journal |author=Tan CD, Baldwin WM, Rodriguez ER |title=Update on cardiac transplantation pathology |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1169–91 |year=2007 |month=August |pmid=17683180 |doi= |url=}}</ref><ref>{{cite journal |author=Olsen SL, Wagoner LE, Hammond EH, ''et al.'' |title=Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations |journal=J. Heart Lung Transplant. |volume=12 |issue=2 |pages=S135–42 |year=1993 |pmid=8476883 |doi= |url=}}</ref> | |||
===Microscopic=== | ===Microscopic=== | ||
Features:<ref>URL: [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4 http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4]. Accessed on: 7 January 2011.</ref> | Features:<ref>URL: [http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4 http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4]. Accessed on: 7 January 2011.</ref> | ||
Line 24: | Line 132: | ||
*Dilated small vessels. | *Dilated small vessels. | ||
*Scant inflammatory infiltrate. | *Scant inflammatory infiltrate. | ||
**Macrophage margination.<ref>{{cite journal |author=Lee CY, Lotfi-Emran S, Erdinc M, ''et al.'' |title=The involvement of FcR mechanisms in antibody-mediated rejection |journal=Transplantation |volume=84 |issue=10 |pages=1324–34 |year=2007 |month=November |pmid=18049118 |doi=10.1097/01.tp.0000287457.54761.53 |url=}}</ref> (???) | |||
Image: | Image: | ||
*[http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4 Acute rejection (pathconsultddx.com)]. | *[http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4 Acute rejection (pathconsultddx.com)]. | ||
== | ===IHC=== | ||
Grading scheme 2004/1990:<ref>{{Ref WMSP|136}}</ref> | Features:<ref name=pmid17683180>{{cite journal |author=Tan CD, Baldwin WM, Rodriguez ER |title=Update on cardiac transplantation pathology |journal=Arch. Pathol. Lab. Med. |volume=131 |issue=8 |pages=1169–91 |year=2007 |month=August |pmid=17683180 |doi= |url=}}</ref> | ||
*[[C4d]]. | |||
*C3d. | |||
==Acute cellular rejection== | |||
===General=== | |||
*Common form of rejection. | |||
===Microscopic=== | |||
Features: | |||
*Perivascular lymphocytic infiltrate, usu. deep. | |||
*Reactive endothelium. | |||
*+/-Myocardial eosinophilia. | |||
*+/-Expansion of perivascular space. | |||
Notes: | |||
*The main DDx is a Quilty lesion - these are attached to the surface and are typically not associated with a blood vessel. | |||
===Grading - comparison=== | |||
Grading scheme 2004/1990:<ref name=Ref_WMSP136>{{Ref WMSP|136}}</ref> | |||
{| class="wikitable" | {| class="wikitable" | ||
| Grade 2004 | | Grade 2004 | ||
Line 81: | Line 209: | ||
==Chronic rejection== | ==Chronic rejection== | ||
===General=== | |||
*[[AKA]] ''transplant arteriopathy'' or ''cardiac allograft vasculopathy''. | |||
*Thought to be a form of accelerated atherosclerosis.<ref name=Ref_WMSP137>{{Ref WMSP|137}}</ref> | |||
===Microscopic=== | ===Microscopic=== | ||
Line 92: | Line 223: | ||
Notes: | Notes: | ||
* | *Morphologically vaguely similar to atherosclerosis. | ||
=Other= | |||
==Post-transplant lymphoproliferative disorder== | |||
{{Main|Post-transplant lymphoproliferative disorder}} | |||
*Abbreviated ''PTLD''. | |||
===General=== | |||
*Rare. | |||
*Associated with [[EBV]].<ref>URL: [http://emedicine.medscape.com/article/431364-overview http://emedicine.medscape.com/article/431364-overview]. Accessed on: 10 February 2011.</ref> | |||
===Microscopic=== | |||
Features: | |||
*Large cell lymphoma - see [[DLBCL]]. | |||
=See also= | |||
*[[Heart]]. | *[[Heart]]. | ||
*[[Lung transplant pathology]]. | *[[Lung transplant pathology]]. | ||
=References= | |||
{{Reflist| | {{Reflist|2}} | ||
=External links= | |||
*[http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970592-7 Heart transplant rejection (pathconsultddx.com)]. | *[http://www.pathconsultddx.com/pathCon/diagnosis?pii=S1559-8675%2806%2970592-7 Heart transplant rejection (pathconsultddx.com)]. | ||
*[http://emedicine.medscape.com/article/1612493-overview Heart transplant rejection (emedicine.medscape.com)]. | |||
[[Category: Cardiovascular pathology]] | [[Category: Cardiovascular pathology]] |
Latest revision as of 18:28, 22 November 2011
Heart transplant pathology is a niche in cardiac pathology.
Overview - table
Types of rejection[1]
Type (grade) | Description | Details | Image |
antibody-mediated rejection (acute vascular) | edema, dilated small vessels | scant inflammation | acute |
normal (0R) | normal | no extravascular monocytes | |
acute cellular (1R) | (perivascular) inflammatory infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmacytic), scant damage | mild cellular |
acute cellular (2R) | (perivascular) inflammatory space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmacytic), obvious damage (myocyte eosinophilia or drop-out) | mod. cellular, mod. cellular resolving |
acute cellular (3R) | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss/damage | |
chronic | concentric intimal thicking | internal elastic lamina preserved (unlike atherosclerosis) | chronic, chronic |
Pitfalls[1]
Name | Description | Details | Image |
Quilty effect | endocardial/subendocardial B-lymphocytes (in clusters) | may extend into myocardium, not assoc. with blood vessels +/-myocyte damage; benign behaviour clinically | Quilty effect, Quilty effect |
Old biopsy site | hemosiderin-laden macrophages | fibrosis/myocyte replacement | old Bx site |
Mimics
Biopsy site reaction
General
- Can be confused for rejection.
Microscopic
Features:
- Hemosiderin-laden macrophages.
- +/-Fibrosis/myofibre loss-replacement.
- +/-Scant inflammatory infiltration.
Image: Biopsy site (pathconsultddx.com).
Quilty effect
General
- Can be confused for rejection.
- Benign behaviour.
Trivia:
- The name Quilty comes from the patient in which this was first recognized.
Microscopic
Features:[3]
- Lymphocytes in clusters (B cells and T cells).
- Associated with the endocardium ("endothelium of the heart"), i.e. on the surface - key feature.
- Often have capillaries in centre; usu. not associated with large blood vessels.
- Lymphocytes separated by collagen.
Notes:
- No longer subclassified.[2]
- Traditional classification (by location):
- Quilty A: Endocardial/subendocardial.
- Quilty B: Endocardial/subendocardial + myocardium.
- +/-Myocyte damage.[4]
- Traditional classification (by location):
Images:
IHC
Mix of T cell and B cells:[3]
- CD3 +ve.
- CD20 +ve.
Notes:
- ACR is T cells.[3]
Coronary atherosclerosis (ischemic injury)
General
- Usu. early - related to atherosclerosis in the donor heart.
- Not typically biopsied. (???)
Microscopic
Features:
- Findings seen in atherosclerosis.
Rejection
It comes in different flavours:[5]
- Antibody-mediated rejection (acute vascular rejection).
- Acute cellular rejection.
- Chronic rejection.
Antibody-mediated rejection
- Abbreviated as AMR.
General
Microscopic
Features:[7]
- Edema.
- Dilated small vessels.
- Scant inflammatory infiltrate.
- Macrophage margination.[8] (???)
Image:
IHC
Features:[2]
- C4d.
- C3d.
Acute cellular rejection
General
- Common form of rejection.
Microscopic
Features:
- Perivascular lymphocytic infiltrate, usu. deep.
- Reactive endothelium.
- +/-Myocardial eosinophilia.
- +/-Expansion of perivascular space.
Notes:
- The main DDx is a Quilty lesion - these are attached to the surface and are typically not associated with a blood vessel.
Grading - comparison
Grading scheme 2004/1990:[9]
Grade 2004 | Grade 1990 | Description | Details | Image |
0R | 0 | normal | no extravascular monocytes | |
1R | 1A | infiltrate, myocyte damage | scant interstitial infiltrate (lymphoplasmic), scant damage | mild |
1R | 1B | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), focal damage | |
1R | 2 | infiltrate, myocyte damage | diffuse interstitial infiltrate (lymphoplasmic), obvious damage | |
2R | 3A | space-occupying lesion | diffuse interstitial infiltrate displaces parenchyma (lymphoplasmic), obvious damage | mod., mod. resolving |
3R | 3B | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), obvious damage | |
3R | 4 | disruption of normal arch. | diffuse interstitial infiltrate disrupts parenchyma (lymphoplasmic & PMNs), fibre loss |
Chronic rejection
General
- AKA transplant arteriopathy or cardiac allograft vasculopathy.
- Thought to be a form of accelerated atherosclerosis.[10]
Microscopic
Features:[11]
- Concentric intimal thickening.
- Preservation of internal elastic lamina.
Images:
Notes:
- Morphologically vaguely similar to atherosclerosis.
Other
Post-transplant lymphoproliferative disorder
Main article: Post-transplant lymphoproliferative disorder
- Abbreviated PTLD.
General
Microscopic
Features:
- Large cell lymphoma - see DLBCL.
See also
References
- ↑ 1.0 1.1 Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136-7. ISBN 978-0781765275.
- ↑ 2.0 2.1 2.2 2.3 Tan CD, Baldwin WM, Rodriguez ER (August 2007). "Update on cardiac transplantation pathology". Arch. Pathol. Lab. Med. 131 (8): 1169–91. PMID 17683180.
- ↑ 3.0 3.1 3.2 URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 8 March 2011.
- ↑ Winters GL (March 1997). "The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection". Curr. Opin. Cardiol. 12 (2): 146–52. PMID 9192483.
- ↑ URL: http://emedicine.medscape.com/article/1612493-overview. Accessed on: 9 Febraury 2011.
- ↑ Olsen SL, Wagoner LE, Hammond EH, et al. (1993). "Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations". J. Heart Lung Transplant. 12 (2): S135–42. PMID 8476883.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig4. Accessed on: 7 January 2011.
- ↑ Lee CY, Lotfi-Emran S, Erdinc M, et al. (November 2007). "The involvement of FcR mechanisms in antibody-mediated rejection". Transplantation 84 (10): 1324–34. doi:10.1097/01.tp.0000287457.54761.53. PMID 18049118.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 136. ISBN 978-0781765275.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 137. ISBN 978-0781765275.
- ↑ URL: http://www.pathconsultddx.com/pathCon/largeImage?pii=S1559-8675%2806%2970592-7&figureId=fig5. Accessed on: 7 January 2011.
- ↑ URL: http://newsroom.ucla.edu/portal/ucla/ucla-team-uncovers-mechanism-behind-179330.aspx. Accessed on: 7 January 2011.
- ↑ URL: http://emedicine.medscape.com/article/431364-overview. Accessed on: 10 February 2011.